Designing and implementing a new quality control concept in line with the U.S. Pharmaceutical Authority (FDA) requirements. (Q3751766): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
||
| Property / contained in NUTS | |||
| Property / contained in NUTS: Pohjois-Pohjanmaa / rank | |||
Normal rank | |||
Revision as of 09:56, 23 November 2021
Project Q3751766 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Designing and implementing a new quality control concept in line with the U.S. Pharmaceutical Authority (FDA) requirements. |
Project Q3751766 in France |
Statements
85,310 Euro
0 references
197,431.0 Euro
0 references
43.21 percent
0 references
21 December 2017
0 references
31 March 2019
0 references
PHARMATORY OY
0 references
65°2'59.10"N, 25°32'43.91"E
0 references
90620
0 references
Hankkeen pääasiallisena tavoitteena on liiketoiminnan kansainvälistäminen ja vankan jalansijan saavuttaminen USA:n markkinoilla. Tämä edellyttää toiminnalta FDA-vaatimusten mukaisuutta. Toimenpiteinä suunnitellaan ja toteutetaan analyysi- ja laadunvalvontalaboratorion laajennus ja uudistus koskien sekä laitekantaa että ohjelmistoja ja tietojärjestelmää. Uudistuksen tuloksena yritys pystyy tarjoamaan palveluita USA:n lääkemarkkinoille kyberturvallisuus huomioiden. (Finnish)
0 references
The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking into account cybersecurity. (English)
23 November 2021
0 references